M Aslam1, S V Madhu2. 1. Department of Endocrinology, Centre for Diabetes Endocrinology & Metabolism, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India. 2. Department of Endocrinology, Centre for Diabetes Endocrinology & Metabolism, University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, India. drsvmadhu@gmail.com.
Abstract
PURPOSE: Association of circulating adiponectin levels with metabolic syndrome has been controversial, with studies reporting low as well as high circulating adiponectin levels in metabolic syndrome. Present study aims to examine prospectively the course of circulating adiponectin levels during development of metabolic syndrome in a diet-induced rat model of metabolic syndrome. METHODS: In a prospective study, eight-week-old male wistar rats were randomized into two groups (n = 24 each). Group A: standard chow diet and group B: high sucrose diet. Body weight, total and high molecular weight (HMW) adiponectin and insulin levels were measured during the study. Oral fat and glucose tolerance tests were done during the study at various time points from weeks 2 to 26. Visceral fat, subcutaneous fat, and adiponectin levels were also measured at week 48 in some of the rats. RESULTS: Significantly higher total adiponectin levels were found from week 2 to 26 in group B compared to group A (P = <0.05), whereas HMW adiponectin levels were similar in both the groups. Postprandial triglycerides, obesity, insulin resistance, and glucose intolerance were also found to be significantly higher in group B compared to group A during this period (P = <0.05). Total adiponectin levels of week 26 showed significant positive correlation with preceding postprandial triglyceride burden in group B (r = 0.60, P = 0.002). CONCLUSION: In conclusion, the present study finds that development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in circulating adiponectin levels.
PURPOSE: Association of circulating adiponectin levels with metabolic syndrome has been controversial, with studies reporting low as well as high circulating adiponectin levels in metabolic syndrome. Present study aims to examine prospectively the course of circulating adiponectin levels during development of metabolic syndrome in a diet-induced rat model of metabolic syndrome. METHODS: In a prospective study, eight-week-old male wistar rats were randomized into two groups (n = 24 each). Group A: standard chow diet and group B: high sucrose diet. Body weight, total and high molecular weight (HMW) adiponectin and insulin levels were measured during the study. Oral fat and glucose tolerance tests were done during the study at various time points from weeks 2 to 26. Visceral fat, subcutaneous fat, and adiponectin levels were also measured at week 48 in some of the rats. RESULTS: Significantly higher total adiponectin levels were found from week 2 to 26 in group B compared to group A (P = <0.05), whereas HMW adiponectin levels were similar in both the groups. Postprandial triglycerides, obesity, insulin resistance, and glucose intolerance were also found to be significantly higher in group B compared to group A during this period (P = <0.05). Total adiponectin levels of week 26 showed significant positive correlation with preceding postprandial triglyceride burden in group B (r = 0.60, P = 0.002). CONCLUSION: In conclusion, the present study finds that development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in circulating adiponectin levels.
Authors: John A Morrison; Charles J Glueck; Stephen Daniels; Ping Wang; Paul Horn; Davis Stroop Journal: Transl Res Date: 2010-09-08 Impact factor: 7.012
Authors: Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa Journal: Biochem Biophys Res Commun Date: 1999-04-02 Impact factor: 3.575
Authors: James M Shikany; Cora E Lewis; Barry I Freedman; Donna K Arnett; Catherine Leiendecker-Foster; Tamekia L Jones; David T Redden; Albert Oberman Journal: Metabolism Date: 2007-08 Impact factor: 8.694
Authors: Robert K Semple; Nils H Halberg; Keith Burling; Maria A Soos; Todd Schraw; Jian'an Luan; Elaine K Cochran; David B Dunger; Nicholas J Wareham; Philipp E Scherer; Phillip Gorden; Stephen O'Rahilly Journal: Diabetes Date: 2007-02-26 Impact factor: 9.461
Authors: Silvia Moreno-Fernández; Marta Garcés-Rimón; Gema Vera; Julien Astier; Jean François Landrier; Marta Miguel Journal: Nutrients Date: 2018-10-14 Impact factor: 5.717
Authors: Daniel González-Hedström; Ángel Luís García-Villalón; Sara Amor; María de la Fuente-Fernández; Paula Almodóvar; Marin Prodanov; Teresa Priego; Ana Isabel Martín; Antonio Manuel Inarejos-García; Miriam Granado Journal: Sci Rep Date: 2021-04-14 Impact factor: 4.379
Authors: Giuseppe Petito; Federica Cioffi; Elena Silvestri; Rita De Matteis; Davide Lattanzi; Pieter de Lange; Assunta Lombardi; Maria Moreno; Fernando Goglia; Antonia Lanni; Rosalba Senese Journal: Front Endocrinol (Lausanne) Date: 2021-07-12 Impact factor: 5.555